Human evidence record · Hexarelin
Hexarelin GH response in healthy men
Hexarelin produced dose-dependent GH release.
Quick read
Human evidence record
What this study tells us
This study compared groups, which is more informative than an uncontrolled report. The amount of confidence still depends on how the groups were formed, how outcomes were measured and how well bias was controlled.
Who was studied?
Healthy men
How many?
n=12
What happened?
Hexarelin produced dose-dependent GH release.
What stops us overclaiming?
Very small study; no evidence of improved body composition, recovery or longevity.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
Hexarelin produced dose-dependent GH release.
Study details
Study designPlacebo-controlled dose-response study
PopulationHealthy men
Sample size12
RouteIntravenous
Regimen / exposure0.5, 1 or 2 micrograms/kg
DurationSingle-dose
ComparatorPlacebo / dose groups
Primary endpoint / questionGrowth-hormone response
Safety resultAcute endocrine study only.
Key limitationsVery small study; no evidence of improved body composition, recovery or longevity.
Registry / identifierPMID 7957536